The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Access to medicines – September 2019
The April 2019 Board meeting covered
- the discussion on the EAHP opinion on pricing
- the revision of the ageing society position paper
- EURIPID kick-off event for stakeholders
- COM HTA Stakeholder Pool event in March
Access to medicines
Ageing society
- EAHP’s new position paper on an ageing society was shared with and welcomed by AGE Platform
EURIPID
- DM will attended the last EURIPID meeting held on 23rd September in Hungary. She will report back during the Board meeting
Procurement | FEEDBACK NEEDED from Board leads
- Conference call between procurement Board leads and Medicines for Europe WG to be held in October
- Date not yet determined
- Procurement Board leads to communicate availability
Orphan regulation/ Paediatric Regulation
- Topic will become relevant in early 2020
- COM plans to publish its recommendations
HTA
Draft Regulation on HTA
- MEP Wölken (S&D; German) appointed as new rapporteur
- FI Council Presidency seeks to reach agreement on Articles 1 to 8
- No future plans to organise a meeting of the HTA Stakeholder network
Biosimilars
COM Stakeholder event | DECISION NEEDED
- Taking place on 30th October
- EAHP will be invited – NEW invitation was shared on 23/9 (invitation letter | agenda | response form)
- PH cannot attend
- 1 Board member is needed; SK can accompany him/her